Promising new combo for rare cancer shows early hope
Disease control
Recruiting now
This study tests a combination of two drugs, ATRA and cemiplimab, in people with advanced leiomyosarcoma that has worsened after standard treatments. The goal is to see if this combination can shrink tumors or slow the disease. About 16 adults will take part, receiving ATRA pills…
Phase: PHASE2 • Sponsor: Gabriel Tinoco • Aim: Disease control
Last updated May 08, 2026 14:59 UTC